Cargando…
Topical Delivery of Senicapoc Nanoliposomal Formulation for Ocular Surface Treatments
Topical ophthalmologic treatments have been facing great challenges with main limitations of low drug bioavailability, due to highly integrative defense mechanisms of the eye. This study rationally devised strategies to increase drug bioavailability by increasing ocular surface residence time of dru...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213297/ https://www.ncbi.nlm.nih.gov/pubmed/30274277 http://dx.doi.org/10.3390/ijms19102977 |
_version_ | 1783367735620665344 |
---|---|
author | Phua, Jie Liang Hou, Aihua Lui, Yuan Siang Bose, Tanima Chandy, George Kanianthara Tong, Louis Venkatraman, Subbu Huang, Yingying |
author_facet | Phua, Jie Liang Hou, Aihua Lui, Yuan Siang Bose, Tanima Chandy, George Kanianthara Tong, Louis Venkatraman, Subbu Huang, Yingying |
author_sort | Phua, Jie Liang |
collection | PubMed |
description | Topical ophthalmologic treatments have been facing great challenges with main limitations of low drug bioavailability, due to highly integrative defense mechanisms of the eye. This study rationally devised strategies to increase drug bioavailability by increasing ocular surface residence time of drug-loaded nanoliposomes dispersed within thermo-sensitive hydrogels (Pluronic F-127). Alternatively, we utilized sub-conjunctival injections as a depot technique to localize nanoliposomes. Senicapoc was encapsulated and sustainably released from free nanoliposomes and hydrogels formulations in vitro. Residence time increased up to 12-fold (60 min) with 24% hydrogel formulations, as compared to 5 min for free liposomes, which was observed in the eyes of Sprague-Dawley rats using fluorescence measurements. Pharmacokinetic results obtained from flushed tears, also showed that the hydrogels had greater drug retention capabilities to that of topical viscous solutions for up to 60 min. Senicapoc also remained quantifiable within sub-conjunctival tissues for up to 24 h post-injection. |
format | Online Article Text |
id | pubmed-6213297 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62132972018-11-14 Topical Delivery of Senicapoc Nanoliposomal Formulation for Ocular Surface Treatments Phua, Jie Liang Hou, Aihua Lui, Yuan Siang Bose, Tanima Chandy, George Kanianthara Tong, Louis Venkatraman, Subbu Huang, Yingying Int J Mol Sci Article Topical ophthalmologic treatments have been facing great challenges with main limitations of low drug bioavailability, due to highly integrative defense mechanisms of the eye. This study rationally devised strategies to increase drug bioavailability by increasing ocular surface residence time of drug-loaded nanoliposomes dispersed within thermo-sensitive hydrogels (Pluronic F-127). Alternatively, we utilized sub-conjunctival injections as a depot technique to localize nanoliposomes. Senicapoc was encapsulated and sustainably released from free nanoliposomes and hydrogels formulations in vitro. Residence time increased up to 12-fold (60 min) with 24% hydrogel formulations, as compared to 5 min for free liposomes, which was observed in the eyes of Sprague-Dawley rats using fluorescence measurements. Pharmacokinetic results obtained from flushed tears, also showed that the hydrogels had greater drug retention capabilities to that of topical viscous solutions for up to 60 min. Senicapoc also remained quantifiable within sub-conjunctival tissues for up to 24 h post-injection. MDPI 2018-09-29 /pmc/articles/PMC6213297/ /pubmed/30274277 http://dx.doi.org/10.3390/ijms19102977 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Phua, Jie Liang Hou, Aihua Lui, Yuan Siang Bose, Tanima Chandy, George Kanianthara Tong, Louis Venkatraman, Subbu Huang, Yingying Topical Delivery of Senicapoc Nanoliposomal Formulation for Ocular Surface Treatments |
title | Topical Delivery of Senicapoc Nanoliposomal Formulation for Ocular Surface Treatments |
title_full | Topical Delivery of Senicapoc Nanoliposomal Formulation for Ocular Surface Treatments |
title_fullStr | Topical Delivery of Senicapoc Nanoliposomal Formulation for Ocular Surface Treatments |
title_full_unstemmed | Topical Delivery of Senicapoc Nanoliposomal Formulation for Ocular Surface Treatments |
title_short | Topical Delivery of Senicapoc Nanoliposomal Formulation for Ocular Surface Treatments |
title_sort | topical delivery of senicapoc nanoliposomal formulation for ocular surface treatments |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213297/ https://www.ncbi.nlm.nih.gov/pubmed/30274277 http://dx.doi.org/10.3390/ijms19102977 |
work_keys_str_mv | AT phuajieliang topicaldeliveryofsenicapocnanoliposomalformulationforocularsurfacetreatments AT houaihua topicaldeliveryofsenicapocnanoliposomalformulationforocularsurfacetreatments AT luiyuansiang topicaldeliveryofsenicapocnanoliposomalformulationforocularsurfacetreatments AT bosetanima topicaldeliveryofsenicapocnanoliposomalformulationforocularsurfacetreatments AT chandygeorgekanianthara topicaldeliveryofsenicapocnanoliposomalformulationforocularsurfacetreatments AT tonglouis topicaldeliveryofsenicapocnanoliposomalformulationforocularsurfacetreatments AT venkatramansubbu topicaldeliveryofsenicapocnanoliposomalformulationforocularsurfacetreatments AT huangyingying topicaldeliveryofsenicapocnanoliposomalformulationforocularsurfacetreatments |